Delivery Order SPE2DB22D2006-SPE2DB25FW3UV
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $15,780.47 to AmerisourceBergen Drug Corp for TALTZ 80 mg/mL auto-injector (2-pack) pharmaceutical supplies. This firm fixed price contract, awarded on September 2, 2025, with an ultimate completion date of September 3, 2025, represents a non-set-aside competitive award. The place of performance is located in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters. This delivery order is issued under...
- The Defense Logistics Agency awarded a $10,932.80 delivery order to AmerisourceBergen Drug Corp on August 6, 2025, for the supply of TALTZ 80 mg/ml autoinjectors. This is a firm fixed price, competitively awarded contract with performance at the contractor's Conshohocken, Pennsylvania facility, with an ultimate completion date of August 7, 2025. The award represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued...
- The Defense Logistics Agency awarded a $3,346.05 delivery order to AmerisourceBergen Drug Corp for TALTZ 80 mg/ml auto-injector on September 9, 2025, with completion targeted for September 10, 2025. This competitively awarded, firm fixed-price contract represents a pediatric delivery order issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 through December 2026. AmerisourceBergen, headquartered in Conshohocken,...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $17,228.37 on August 11, 2025, for the supply of TALTZ 80 MG/ML AutoInjector (2-pack). This competitively awarded, firm fixed-price delivery order is scheduled for completion by August 12, 2025, with performance at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. The contract utilizes no set-aside provisions and represents a routine pharmaceutical procurement through established federal...
- The Defense Logistics Agency (DLA) awarded AmerisourceBergen Drug Corp a $4,980.90 delivery order on July 14, 2025, for TALTZ 80 mg/ml autoinjector medication, with performance completion targeted for July 15, 2025. This is a firm fixed price, competitively awarded delivery order with no set-aside designation. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, serves as a critical vendor for federal medical procurement across military and...
- The Defense Logistics Agency awarded a delivery order valued at $23,115.58 to AmerisourceBergen Drug Corp for TALTZ 80 mg/ml auto-injector (2-pack), a pharmaceutical product used in the treatment of autoimmune conditions. This competitively awarded, firm fixed-price delivery order was issued on September 4, 2025, with an ultimate completion date of September 5, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order carries...
- The Defense Logistics Agency awarded a delivery order valued at $6,641.22 to AmerisourceBergen Drug Corp for TALTZ 80 mg/ml auto-injector (2-pack) pharmaceutical supplies. This non-set-aside, competitively awarded contract utilizes firm fixed pricing and was executed on September 16, 2025, with an ultimate completion date of September 17, 2025. The product will be delivered to the contractor's facility in Conshohocken, Pennsylvania. This delivery order represents a child contract under...
- The Defense Logistics Agency awarded a delivery order valued at $36,002.28 to AmerisourceBergen Drug Corp for the supply of TALTZ 80 mg/ml auto-injector (2-pack) pharmaceutical products. This competitively awarded, firm fixed-price contract is classified as a child order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a comprehensive $1 billion global pharmaceutical support vehicle running through December 2026. The delivery order has an...
- The Defense Logistics Agency awarded a $19,447.53 delivery order to AmerisourceBergen Drug Corp on August 14, 2025, for the supply of TALTZ 80 MG/ML auto-injector (2-pack) pharmaceutical products. This firm fixed-price delivery order, which concludes on August 15, 2025, represents a competitively awarded contract with no set-aside designation. The products will be delivered to AmerisourceBergen's location in Conshohocken, Pennsylvania, the company's corporate headquarters and a major...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $6,641.24 on August 20, 2025, for the supply of TALTZ 80 mg/ml autoinjector medication. This is a firm fixed price, non-set-aside contract with a completion date of August 21, 2025, and performance location in Conshohocken, Pennsylvania, where the vendor maintains its corporate headquarters. The delivery order represents a single transaction under AmerisourceBergen's larger pharmaceutical supply framework...
- SPE2DB22D2006Indefinite Delivery Contract
- SPE2DB22D2006-SPE2DB25FW3UVDelivery Order
The Defense Logistics Agency awarded a delivery order valued at $13,902.78 to AmerisourceBergen Drug Corp for TALTZ 80 mg/ml auto-injector two-packs. This firm fixed price, competitively awarded contract calls for delivery to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, with completion targeted for August 25, 2025. The award represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, a $999,999,999.00 comprehensive pharmaceutical supply vehicle running through December 2026 that enables the company to distribute a broad range of pharmaceutical products and medical supplies to military healthcare programs globally. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, serves as a critical federal vendor for military and veteran healthcare systems through its extensive portfolio of brand-name and generic medications, vaccines, medical devices, and specialized healthcare commodities. As a non-set-aside award, this delivery order reflects the company's demonstrated capability to meet federal procurement requirements through open competition. The contract fulfills medical supply needs across multiple therapeutic domains and aligns with the company's ongoing role as a prime pharmaceutical vendor supporting the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $13.9k | 8/22/25 |